The Uromigos

Release Date

All Episodes

Episode 519: What is the Appropriate Approach to Adjuvant Therapy for UTUC?

Shilpa Gupta joins us to discuss an X poll revealing equipoise about treatment approaches to resected high-risk upper tract urothelial cancer (UTUC).

. 33min 24sec

Episode 518: PSMAddition in Clinical Practice

Rob Dreicer joins the show to discuss the FDA approval of Lutetium Lu 177 in the mHSPC space and how to contextualize the benefit/risk

. 31min 8sec

Episode 517: Casdatifan Clinical Data in RCC and Translational Correlates

Toni Choueiri joins Brian and Tom to discuss a recent Nature paper regarding the novel HIF inhibitor, casdatifan, and biomarkers of response.

. 40min 53sec

Episode 516: The Influence of Hypoxia on Response and Resistance in RCC

Ari Hakimi and Lyn Voung from MSKCC join Brian and Tom to discuss their recent Cancer Cell paper exploring the mechanistic impact of TKI-induced hypoxia on immune response in RCC.

. 47min 50sec

Episode 515: PROTEUS - A Reflection on the Data and Controversies with Neha Vapiwala

Brian and Tom invite Neha Vapiwala, a Radiation Oncologist, to discuss areas of consensus and controversy from the PROTEUS trial of ADT +/- apalutamide in high-risk localized prostate cancer.

. 43min 6sec